PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

Completed · Not applicable

Conditions studied: Symptomatic Severe Aortic Stenosis

In brief

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, and severe aortic stenosis, and those with intermediate risk.

Key facts

Study ID
NCT03222128
Run by
Edwards Lifesciences
People needed
1074
Starts
2014-02-17
Expected to finish
2024-10-09
Last updated by the study team
2025-01-03

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.